|
| | Publication Year | Title | Author(s) |
| 1 | 2-Feb-2021 | Association of β-amyloid level, clinical progression and longitudinal cognitive change in normal older individuals. | van der Kall, Laura M; Truong, Thanh; Burnham, Samantha C; Doré, Vincent ; Mulligan, Rachel S ; Bozinovski, Svetlana ; Lamb, Fiona ; Bourgeat, Pierrick; Fripp, Jurgen; Schultz, Stephanie; Lim, Yen Y; Laws, Simon M; Ames, David; Fowler, Christopher; Rainey-Smith, Stephanie R; Martins, Ralph N; Salvado, Olivier; Robertson, Joanne; Maruff, Paul; Masters, Colin L ; Villemagne, Victor L ; Rowe, Christopher C |
| 2 | 22-Dec-2020 | Case Report: 18F-MK6240 Tau Positron Emission Tomography Pattern Resembling Chronic Traumatic Encephalopathy in a Retired Australian Rules Football Player. | Krishnadas, Natasha ; Doré, Vincent ; Lamb, Fiona ; Groot, Colin; McCrory, Paul; Guzman, Rodney; Mulligan, Rachel S ; Huang, Kun ; O'Donnell, Meaghan; Ponsford, Jennie; Hopwood, Malcolm; Villemagne, Victor L ; Rowe, Christopher C |
| 3 | 15-Nov-2018 | Diagnostic accuracy of imaging brain vesicular monoamine transporter type 2 (VMAT2) in clinically uncertain parkinsonian syndrome (CUPS): a 3-year follow-up study in community patients. | Xu, San San ; Alexander, Paschal K ; Lie, Yenni; Dore, Vincent; Bozinovski, Svetlana ; Mulligan, Rachel S ; Young, Kenneth ; Villemagne, Victor L ; Rowe, Christopher C |
| 4 | Nov-2017 | 18F-Florbetaben PET beta-amyloid binding expressed in Centiloids | Rowe, Christopher C ; Doré, Vincent ; Jones, Gareth; Baxendale, David; Mulligan, Rachel S ; Bullich, Santiago; Stephens, Andrew W; De Santi, Susan; Masters, Colin L ; Dinkelborg, Ludger; Villemagne, Victor L |
| 5 | Nov-2017 | Management Impact of Imaging Brain Vesicular Monoamine Transporter Type 2 in Clinically Uncertain Parkinsonian Syndrome with 18F-AV133 and PET | Alexander, Paschal K ; Lie, Yenni; Jones, Gareth; Sivaratnam, Chomalaven; Bozinvski, Svetlana; Mulligan, Rachel S ; Young, Kenneth ; Villemagne, Victor L ; Rowe, Christopher C |
| 6 | Aug-2016 | Standardized Expression of 18F-NAV4694 and 11C-PiB β-Amyloid PET Results with the Centiloid Scale. | Rowe, Christopher C ; Jones, Gareth; Doré, Vincent ; Pejoska, Svetlana; Margison, Laura ; Mulligan, Rachel S ; Chan, J Gordon ; Young, Kenneth ; Villemagne, Victor L |
| 7 | 27-Mar-2014 | Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET. | Okamura, Nobuyuki; Furumoto, Shozo; Fodero-Tavoletti, Michelle T; Mulligan, Rachel S ; Harada, Ryuichi; Yates, Paul; Pejoska, Svetlana; Kudo, Yukitsuka; Masters, Colin L ; Yanai, Kazuhiko; Rowe, Christopher C ; Villemagne, Victor L |
| 8 | 26-Feb-2014 | Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathies. | Fodero-Tavoletti, Michelle T; Furumoto, Shozo; Taylor, Leanne; McLean, Catriona A; Mulligan, Rachel S ; Birchall, Ian; Harada, Ryuichi; Masters, Colin L ; Yanai, Kazuhiko; Kudo, Yukitsuka; Rowe, Christopher C ; Okamura, Nobuyuki; Villemagne, Victor L |
| 9 | 11-Feb-2014 | In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease. | Villemagne, Victor L ; Furumoto, Shozo; Fodero-Tavoletti, Michelle T; Mulligan, Rachel S ; Hodges, John; Harada, Ryuichi; Yates, Paul; Piguet, Olivier; Pejoska, Svetlana; Doré, Vincent ; Yanai, Kazuhiko; Masters, Colin L ; Kudo, Yukitsuka; Rowe, Christopher C ; Okamura, Nobuyuki |
| 10 | 1-Dec-2013 | Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing. | Rowe, Christopher C ; Bourgeat, Pierrick; Ellis, Kathryn A; Brown, Belinda; Lim, Yen Ying; Mulligan, Rachel S ; Jones, Gareth; Maruff, Paul; Woodward, Michael M ; Price, Roger; Robins, Peter; Tochon-Danguy, Henri; O'Keefe, Graeme J; Pike, Kerryn E; Yates, Paul; Szoeke, Cassandra; Salvado, Olivier; Macaulay, S Lance; O'Meara, Timothy; Head, Richard; Cobiac, Lynne; Savage, Greg; Martins, Ralph N; Masters, Colin L ; Ames, David; Villemagne, Victor L |
| 11 | 10-Apr-2013 | Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia. | Rowe, Christopher C ; Pejoska, Svetlana; Mulligan, Rachel S ; Jones, Gareth; Chan, J Gordon ; Svensson, Samuel; Cselényi, Zsolt; Masters, Colin L ; Villemagne, Victor L |
| 12 | 16-Jan-2013 | (18)F-florbetaben Aβ imaging in mild cognitive impairment. | Ong, Kevin; Villemagne, Victor L ; Bahar-Fuchs, Alex; Lamb, Fiona ; Chételat, Gaël; Raniga, Parnesh; Mulligan, Rachel S ; Salvado, Olivier; Putz, Barbara; Roth, Katrin; Masters, Colin L ; Reininger, Cornelia B; Rowe, Christopher C |
| 13 | 8-Mar-2012 | Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease. | Villemagne, Victor L ; Mulligan, Rachel S ; Pejoska, Svetlana; Ong, Kevin; Jones, Gareth; O'Keefe, Graeme J; Chan, J Gordon ; Young, Kenneth ; Tochon-Danguy, Henri; Masters, Colin L ; Rowe, Christopher C |
| 14 | 15-Jul-2011 | Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias. | Villemagne, Victor L ; Ong, Kevin; Mulligan, Rachel S ; Holl, Gerhard; Pejoska, Svetlana; Jones, Gareth; O'Keefe, Graeme J; Ackerman, Uwe; Tochon-Danguy, Henri; Chan, J Gordon ; Reininger, Cornelia B; Fels, Lueder; Putz, Barbara; Rohde, Beate; Masters, Colin L ; Rowe, Christopher C |
| 15 | 1-Jul-2011 | In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease. | Villemagne, Victor L ; Okamura, Nobuyuki; Pejoska, Svetlana; Drago, John; Mulligan, Rachel S ; Chételat, Gaël; Ackermann, Uwe ; O'Keefe, Graeme J; Jones, Gareth; Gong, Sylvia J; Tochon-Danguy, Henry; Kung, Hank F; Masters, Colin L ; Skovronsky, Daniel M; Rowe, Christopher C |
| 16 | 1-Jan-2011 | Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. | Villemagne, Victor L ; Pike, Kerryn E; Chételat, Gaël; Ellis, Kathryn A; Mulligan, Rachel S ; Bourgeat, Pierrick; Ackermann, Uwe ; Jones, Gareth; Szoeke, Cassandra; Salvado, Olivier; Martins, Ralph N; O'Keefe, Graeme J; Mathis, Chester A; Klunk, William E; Ames, David; Masters, Colin L ; Rowe, Christopher C |
| 17 | 2011 | Quantitative approaches to amyloid imaging. | Villemagne, Victor L ; O'Keefe, Graeme J; Mulligan, Rachel S ; Rowe, Christopher C |
| 18 | 15-Jan-2010 | In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133. | Okamura, Nobuyuki; Villemagne, Victor L ; Drago, John; Pejoska, Svetlana; Dhamija, Rajinder K; Mulligan, Rachel S ; Ellis, Julia R; Ackermann, Uwe ; O'Keefe, Graeme J; Jones, Gareth; Kung, Hank F; Pontecorvo, Michael J; Skovronsky, Daniel; Rowe, Christopher C |
| 19 | 1-Dec-2009 | High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types. | Villemagne, Victor L ; Ataka, Suzuka; Mizuno, Toshiki; Brooks, William S; Wada, Yasuhiro; Kondo, Masaki; Jones, Gareth; Watanabe, Yasuyoshi; Mulligan, Rachel S ; Nakagawa, Masanori; Miki, Takami; Shimada, Hiroyuki; O'Keefe, Graeme J; Masters, Colin L ; Mori, Hiroshi; Rowe, Christopher C |
| 20 | 11-Jul-2008 | Relationship between nicotinic receptors and cognitive function in early Alzheimer's disease: a 2-[18F]fluoro-A-85380 PET study. | Ellis, J R; Villemagne, Victor L ; Nathan, P J; Mulligan, Rachel S ; Gong, Sylvia J; Chan, J Gordon ; Sachinidis, John I; O'Keefe, Graeme J; Pathmaraj, K ; Wesnes, K A; Savage, Greg; Rowe, Christopher C |
Loading...
2
0
5
0
false